89bio, Inc. (ETNB) Misses Q4 EPS by 27c

89bio, Inc. (NASDAQ: ETNB) reported Q4 EPS of ($1.02), $0.27 worse than the analyst estimate of ($0.75).

For earnings history and earnings-related data on 89bio, Inc. (ETNB) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Q1 EPS miss sends shares down 9% after-hours
• Axis Capital Limited Downgrades Wipro Ltd. (WPRO:IN) (WIT) to Reduce (3)